Medical Devices: Evidence and Research (Mar 2021)
Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results [Corrigendum]
Abstract
Christoffel L, Römer T, Schiermeier S. Med Devices (Auckl). 2021;14:77— 84. Page 83, left column, lines 7-9, it is stated that “These initial results corroborate those from previous clinical trials, as well as over 600 commercial cases worldwide”. The text should read: “. . .as well as over 1,600 commercial cases worldwide”. The authors apologize for this error. Read the original article